ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2014

Heterozygote advantage of methylenetetrahydrofolate reductase polymorphisms on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy.

Xiaoying Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.